OMMAX advised the UK's No. 1 Vitamin Company, Vitabiotics, on Vendor Due Diligence and Exit Readiness in Bain Capital's $1.2 Billion Acquisition

OMMAX, the AI-first consultancy and AI-engineering platform, is pleased to announce that it advised Vitabiotics, the UK's leading vitamins, minerals and supplements company, on its Vendor Due Diligence and Exit Readiness process ahead of its acquisition by Bain Capital.

The transaction represents a significant milestone in Vitabiotics' 55-year history and positions the company for its next phase of international expansion. Bain Capital has agreed to acquire Vitabiotics and the wider VB Group, creating a strong platform for continued global growth.

OMMAX supported the management team and shareholders throughout the Vendor Due Diligence and Exit Readiness process. The engagement focused on assessing the company's digital capabilities, e-commerce performance, customer acquisition, AI readiness, international growth opportunities and overall digital value creation story to support a successful transaction process.

Stefan Sambol, Founding Partner at OMMAX, said:

"We are proud to have supported Vitabiotics and its shareholders throughout the Vendor Due Diligence and Exit Readiness process. As investors increasingly evaluate companies through the lens of digital capabilities, AI readiness and scalable growth, comprehensive preparation has become a critical success factor in achieving outstanding transaction outcomes. We congratulate Tej Lalvani, the Vitabiotics team and Bain Capital on this milestone."

About Vitabiotics 

Vitabiotics’s mission is to empower wellness and healthy living through innovation in nutritional healthcare. The company has pioneered advances in nutritional healthcare for 55 years, with a portfolio that includes some of Britain’s leading and most trusted supplement brands such as Perfectil, Pregnacare, Wellman, Wellwoman and Menopace. 

Vitabiotics is the leading British nutraceutical company founded in 1971 by Professor Kartar Lalvani, with a heritage deeply rooted in family entrepreneurship and scientific research. Built on a foundation of clinical insight into nutritional science, the company developed some of the UK’s most trusted supplement brands, including Perfectil, Pregnacare, Wellman, Wellwoman, and Menopace. It has grown into a category-defining business in vitamins and mineral-based food supplements, with products spanning key health areas and life stages, including pregnancy, men’s and women’s health, beauty, and family nutrition. In 2013, Vitabiotics became the UK’s largest vitamin company by sales value, reflecting its strong market position and sustained consumer trust. 

As the UK’s No.1 vitamin company, Vitabiotics UK exports to over 70 countries worldwide. Alongside its international export business, the Group has established operations in key global markets including India, China, Egypt and West Africa, reflecting its evolution into a leading international nutritional healthcare company. Vitabiotics is the only vitamin company to have received the Queen’s Award for Enterprise on four occasions, including twice for Innovation (in 2013 for Pregnacare and in 2018 for Perfectil). Vitabiotics also supports ongoing research and original clinical trials in collaboration with universities and leading medical centres in the UK and internationally. 

About Bain Capital 

Founded in 1984, Bain Capital is one of the world’s leading private investment firms. We are committed to creating lasting impact for our investors, portfolio companies, and the communities in which we live. As a private partnership, we lead with conviction and a culture of collaboration, advantages that enable us to innovate investment approaches, unlock opportunities, and create exceptional outcomes. Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. In these focus areas, we bring deep sector expertise and wide-ranging capabilities. We have 24 offices on four continents, more than 1,900 employees, and approximately $225 billion in assets under management.

About OMMAX 

OMMAX is a leading AI-first consultancy and AI-engineering platform specializing in AI strategy, business transformation, transaction advisory, and value creation in the age of AI. Founded in Munich in 2011, OMMAX serves large corporates, mid-sized companies, and private equity firms across Europe and the US, with more than 4,000 completed projects and a Net Promoter Score of 90.